RFERENCES
1. Mannucci E, Silverii A, Monami M. Association between different
screening strategies for SARS-CoV-2 and deaths and severe disease in
Italy. International journal of clinical practice . Nov 24
2020:e13867. doi:10.1111/ijcp.13867
2. Ozcelik F, Tanoglu A, Guven BB, Keskin U, Kaplan M. Assessment of
severity and mortality of COVID-19 with anti-A1 and B IgM
isohemagglutinins, a reflection of the innate immune status.International journal of clinical practice . Jul 12 2021:e14624.
doi:10.1111/ijcp.14624
3. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting
Characteristics, Comorbidities, and Outcomes Among 5700 Patients
Hospitalized With COVID-19 in the New York City Area. Jama . May
26 2020;323(20):2052-2059. doi:10.1001/jama.2020.6775
4. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus
Disease 2019 in China. The New England journal of medicine . Apr
30 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
5. Bertolini A, van de Peppel IP, Bodewes F, et al. Abnormal Liver
Function Tests in Patients With COVID-19: Relevance and Potential
Pathogenesis. Hepatology . Nov 2020;72(5):1864-1872.
doi:10.1002/hep.31480
6. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2
is a functional receptor for the SARS coronavirus. Nature . Nov 27
2003;426(6965):450-4. doi:10.1038/nature02145
7. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry
Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven
Protease Inhibitor. Cell . Apr 16 2020;181(2):271-280 e8.
doi:10.1016/j.cell.2020.02.052
8. Ali N, Hossain K. Liver injury in severe COVID-19 infection: current
insights and challenges. Expert review of gastroenterology &
hepatology . Oct 2020;14(10):879-884. doi:10.1080/17474124.2020.1794812
9. Yang R, Gui X, Ke H, Gao S, Luo M, Xiong Y. The indicative role of
markers for liver injury on the severity and prognosis of coronavirus
disease 2019 patients. European journal of gastroenterology &
hepatology . Oct 29 2020;doi:10.1097/MEG.0000000000001968
10. Organization WH. Assessment tool for laboratories implementing
COVID-19 virus testing: interim guidance, 8 April 2020.https://apps.who.int/iris/handle/10665/331714
11. Bakanligi TCS. COVID-19 (SARS-CoV-2 ENFEKSİYONU) ERİŞKİN HASTA
TEDAVİSİ. October 2020.https://covid19.saglik.gov.tr/TR-66926/eriskin-hasta-tedavisi.html
12. Gao J, Huang X, Gu H, Lou L, Xu Z. Predictive criteria of severe
cases in COVID-19 patients of early stage: A retrospective observational
study. Journal of clinical laboratory analysis . Oct
2020;34(10):e23562. doi:10.1002/jcla.23562
13. Ullah W, Thalambedu N, Haq S, et al. Predictability of CRP and
D-Dimer levels for in-hospital outcomes and mortality of COVID-19.Journal of community hospital internal medicine perspectives . Sep
3 2020;10(5):402-408. doi:10.1080/20009666.2020.1798141
14. Katzenschlager S, Zimmer AJ, Gottschalk C, et al. Can we predict the
severe course of COVID-19 - a systematic review and meta-analysis of
indicators of clinical outcome? medRxiv : the preprint server for
health sciences . Nov 12 2020;doi:10.1101/2020.11.09.20228858
15. Zeng F, Deng G, Cui Y, et al. A predictive model for the severity of
COVID-19 in elderly patients. Aging . Nov 10
2020;12(21):20982-20996. doi:10.18632/aging.103980
16. Mudatsir M, Fajar JK, Wulandari L, et al. Predictors of COVID-19
severity: a systematic review and meta-analysis. F1000Research .
2020;9:1107. doi:10.12688/f1000research.26186.1
17. Ramachandran P, Perisetti A, Gajendran M, Chakraborti A, Narh JT,
Goyal H. Increased Serum Aminotransferase Activity and Clinical Outcomes
in Coronavirus Disease 2019. Journal of clinical and experimental
hepatology . Nov-Dec 2020;10(6):533-539. doi:10.1016/j.jceh.2020.06.009
18. Medetalibeyoglu A, Catma Y, Senkal N, et al. The effect of liver
test abnormalities on the prognosis of COVID-19. Annals of
hepatology . Nov - Dec 2020;19(6):614-621.
doi:10.1016/j.aohep.2020.08.068
19. Ponziani FR, Del Zompo F, Nesci A, et al. Liver involvement is not
associated with mortality: results from a large cohort of
SARS-CoV-2-positive patients. Alimentary pharmacology &
therapeutics . Sep 2020;52(6):1060-1068. doi:10.1111/apt.15996
20. Bernal-Monterde V, Casas-Deza D, Letona-Gimenez L, et al. SARS-CoV-2
Infection Induces a Dual Response in Liver Function Tests: Association
with Mortality during Hospitalization. Biomedicines . Sep 4
2020;8(9)doi:10.3390/biomedicines8090328
21. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in
COVID-19 patients: A retrospective analysis of 115 cases from a single
centre in Wuhan city, China. Liver Int . Sep 2020;40(9):2095-2103.
doi:10.1111/liv.14455
22. Shao T, Tong Y, Lu S, et al. gamma-Glutamyltransferase Elevations
Are Frequent in Patients With COVID-19: A Clinical Epidemiologic Study.Hepatology communications . Jul 11 2020;doi:10.1002/hep4.1576
23. Wu Y, Li H, Guo X, et al. Incidence, risk factors, and prognosis of
abnormal liver biochemical tests in COVID-19 patients: a systematic
review and meta-analysis. Hepatology international . Sep
2020;14(5):621-637. doi:10.1007/s12072-020-10074-6